501 Ventures, LLC is a Life Science Accelerator that helps infuse science with development and commercialization expertise.
We provide a turn key solution for innovation that is looking to progress. Our team manages 3-5 independent programs simultaneously and outsources minimal work, providing efficiency of all resources- financial, time, and talent.
Typical programs are:
We are currently reviewing clinical stage assets that are in need of funding and a management team. Please contact email@example.com
TARGET PharmaSolutions, Aerial Bio, GlaxoSmithKline, Eli Lilly, McKinsey
GlaxoSmithKline, Eli Lilly, ZS Associates
Emergo Bio, Kowa Research Institute, Impact Pharmaceutical Services, Lineberry Research Associates (CRO)
Emergo Bio, Aerial Bio, Neuronex, Addrenex, GlaxoWellcome, Cytran, and Lineberry Research Associates (CRO)
Eli Lilly, BMS, Amgen
eGenesis, Lycera, TEVA, TPG
Copyright © 2020 501 Ventures - All Rights Reserved.